Immunovant Inc (NASDAQ:IMVT)’s traded shares stood at 1.07 million during the last session, with the company’s beta value hitting 0.61. At the close of trading, the stock’s price was $14.41, to imply a decrease of -3.93% or -$0.59 in intraday trading. The IMVT share’s 52-week high remains $34.47, putting it -139.21% down since that peak but still an impressive 11.73% since price per share fell to its 52-week low of $12.72.
Analysts have given a consensus recommendation of Buy for Immunovant Inc (IMVT), translating to a mean rating of 1.31. Of 20 analyst(s) looking at the stock, 1 analyst(s) give IMVT a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 13 recommend it as a Buy.
Immunovant Inc (NASDAQ:IMVT) trade information
After registering a -3.93% downside in the last session, Immunovant Inc (IMVT) has traded red over the past five days. The 5-day price performance for the stock is 4.57%, and 1.12% over 30 days. With these gigs, the year-to-date price performance is -41.82%.
The extremes give us $5 and $57 for target low and target high price respectively. As such, IMVT has been trading -295.56% off suggested target high and 65.3% from its likely low.
IMVT Dividends
Immunovant Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 6.51 million shares, or about 4.4561% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $171.86 million.
We also have Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Immunovant Inc (IMVT) shares. Going by data provided on Mar 31, 2025 , Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund holds roughly 4.08 shares. This is just over 2.40% of the total shares, with a market valuation of $58.76 million. Data from the same date shows that the other fund manager holds a little less at 2.08, or 1.22% of the shares, all valued at about 29.93 million.
